Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. Long Term Debt 2020–2025
Tarsus Pharmaceuticals Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Tarsus Pharmaceuticals Inc. long term debt as of December 31, 2025: 72.4M, a 0.83% increase year-over-year.
- Tarsus Pharmaceuticals Inc. long term debt for 2025 were 72.4M, a 0.83% increase from 2024.
- Tarsus Pharmaceuticals Inc. long term debt for 2024 were 71.8M, a 140.94% increase from 2023.
- Tarsus Pharmaceuticals Inc. long term debt for 2023 were 29.8M, a 53.44% increase from 2022.
- Tarsus Pharmaceuticals Inc. long term debt for 2022 were 19.4M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Tarsus Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $72 |
| 2024 | $72 |
| 2023 | $30 |
| 2022 | $19 |
Tarsus Pharmaceuticals Inc. Long Term Debt — FAQ
Tarsus Pharmaceuticals Inc. (TARS) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TARS's long term debt history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.